Inventor · disambiguated record
Caroline Kurtz
Also filed as: KURTZ CAROLINE · KURTZ CAROLINE ISABELLE BACON
7 granted patents·9 pending applications·154 citations·filing 2000–2023
88Inventor score
Files withIRONWOOD PHARMACEUTICALS INC8GELTEX PHARMA INC4SYNLOGIC OPERATING CO INC2GENZYME CORP1MICROBIA INC1
Top patents by PatentIndex Score
16 records- 0196US7494979B2Method for treating congestive heart failure and other disordersIRONWOOD PHARMACEUTICALS INC·Filed 2005·Granted Feb 24, 2009·38 cites·14 claims
- 0293US7772188B2Methods and compositions for the treatment of gastrointestinal disordersIRONWOOD PHARMACEUTICALS INC·Filed 2005·Granted Aug 10, 2010·31 cites·10 claims
- 0390US6290946B1Anionic polymers as toxin binders and antibacterial agentsGELTEX PHARMA INC·Filed 2000·Granted Sep 18, 2001·26 cites·19 claims
- 0487US6482402B1Antimicrobial compositions and methodsGELTEX PHARMA INC·Filed 2000·Granted Nov 19, 2002·24 cites·7 claims
- 0586US6517826B1Anionic polymers as toxin binders and antibacterial agentsGELTEX PHARMA INC·Filed 2000·Granted Feb 11, 2003·16 cites·28 claims
- 0685US2024075094A1Low-Dose Stable Formulations of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0779US6419914B2Anionic polymers as toxin bindersGELTEX PHARMA INC·Filed 2001·Granted Jul 16, 2002·11 cites·24 claims
- 0876US2022031802A1Low-Dose Stable Formulations of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0972US6692732B2Ionic polymers as toxin-binding agentsGENZYME CORP·Filed 2002·Granted Feb 17, 2004·8 cites·19 claims
- 1064US2016310560A1Low-Dose Stable Formulations of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1162US2018015139A1Low-Dose Stable Formulations of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1260US2017157200A1Low-Dose Stable Formulations of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1356US2024197843A1Bacteria engineered to treat disorders in which oxalate is detrimentalSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 1455US2023183295A1Recombinant bacteria for use as a vaccine to prevent covid19 infectionSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 1544US2009253634A1Methods and Compositions for the Treatment of Gastrointestinal DisordersMICROBIA INC·Filed 2006·Application pending·0 cites
- 1641US2013045239A1Method for Modulating the Pharmacodynamic Effect of Orally Administered Guanylate Cyclase Receptor AgonistsIRONWOOD PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Caroline Kurtz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →